Bacteriophage and antibacterial composition comprising the same

US9862935B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-9862935-B2
Application numberUS-201414770420-A
CountryUS
Kind codeB2
Filing dateFeb 24, 2014
Priority dateFeb 27, 2013
Publication dateJan 9, 2018
Grant dateJan 9, 2018

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Provided is a novel bacteriophage ΦCJ20 (KCCM11362P). In addition, the present invention relates to an antibacterial composition including the bacteriophage ΦCJ20 (KCCM11362P) as an active ingredient. Further, the present invention is a method of preventing and/or treating infectious diseases by enterotoxigenic Escherichia coli in animals except for humans using the bacteriophage ΦCJ20 (KCCM11362P) or the antibacterial composition containing the bacteriophage ΦCJ20 (KCCM11362P) as an active ingredient.

First claim

Opening claim text (preview).

The invention claimed is: 1. A method of suppressing or treating an infectious disease caused by ETEC, the method comprising: administering bacteriophage ΦCJ20 (KCCM11362P) to an animal other than human, wherein the bacteriophage ΦCJ20 comprises nucleic acid having SEQ ID NO: 1. 2. The method according to claim 1 , wherein the infectious disease is colibacillosis. 3. A method of suppressing or treating an infectious disease caused by ETEC, the method comprising: administering a composition comprising bacteriophage ΦCJ20 (KCCM11362P) to an animal other than human wherein the bacteriophage ΦCJ20 comprises nucleic acid having SEQ ID NO: 1. 4. The method according to claim 3 , wherein the infectious disease is colibacillosis. 5. A method of preparing an animal feed composition, the method comprising: providing a bacteriophage composition comprising a bacteriophage, said bacteriophage comprising nucleic acid having SEQ ID NO: 1; and mixing the bacteriophage composition with an animal feed base to provide the animal feed composition. 6. The method of claim 5 , wherein the bacteriophage composition prior to mixing is in powder or liquid, wherein the animal feed composition further comprises one or more additives selected from the group consisting of an amino acid, a vitamin, an enzyme, a probiotic, a flavoring agent, a non-protein nitrogen compound, a silicate, a buffer, a coloring agent, an extractant and an oligosaccharide. 7. A method of feeding an animal other than human, the method comprising: providing an animal feed composition comprising a bacteriophage, said bacteriophage comprising nucleic acid having SEQ ID NO: 1; and feeding to the animal other than human the animal feed composition. 8. A method of preparing a drinking water composition, the method comprising: providing a bacteriophage composition comprising a bacteriophage, said bacteriophage comprising nucleic acid having SEQ ID NO: 1; and mixing the bacteriophage composition with drinking water to provide the drinking water composition. 9. The method of claim 8 , wherein the bacteriophage composition prior to mixing is in powder or liquid, wherein the drinking water composition further comprises one or more additives selected from the group consisting of an amino acid, a vitamin, an enzyme, a probiotic, a flavoring agent, a non-protein nitrogen compound, a silicate, a buffer, a coloring agent, an extractant and an oligosaccharide. 10. A method of feeding an animal other than human drinking water, the method comprising: providing a drinking water composition comprising a bacteriophage, said bacteriophage comprising nucleic acid having SEQ ID NO: 1; and feeding to the animal other than human the drinking water composition.

Assignees

Inventors

Classifications

  • Antibacterial agents · CPC title

  • Viruses; Subviral particles; Bacteriophages · CPC title

  • Use of viral protein as therapeutic agent other than vaccine, e.g. apoptosis inducing or anti-inflammatory · CPC title

  • Viruses as such, e.g. new isolates, mutants or their genomic sequences · CPC title

  • Drugs for disorders of the alimentary tract or the digestive system · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US9862935B2 cover?
Provided is a novel bacteriophage ΦCJ20 (KCCM11362P). In addition, the present invention relates to an antibacterial composition including the bacteriophage ΦCJ20 (KCCM11362P) as an active ingredient. Further, the present invention is a method of preventing and/or treating infectious diseases by enterotoxigenic Escherichia coli in animals except for humans using the bacteriophage ΦCJ20 (KCCM1…
Who is the assignee on this patent?
Cj Cheiljedang Corp
What technology area does this patent fall under?
Primary CPC classification C12N7/00. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Jan 09 2018 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).